Advertisement
Join us for “A Comprehensive Review of AUVELITY” a rapid-acting antidepressant that targets both glutamatergic and monoaminergic pathways. This session will explore treatment challenges in MDD, the role of glutamate, and key findings from the ASCEND, GEMINI, and COMET trials. Whether you’re a clinician, researcher, or healthcare professional seeking to expand your understanding of innovative depression therapies, this session will deliver practical and evidence-based perspectives.
Cost: Free for ISAPN members | $25 for non-members
Advertisement
Event Venue & Nearby Stays
Moussalli's Prime, 7415 Marine Rd, Edwardsville, IL 62025-4551, United States
Tickets
